PPC
AMRX icon

Park Place Capital’s Amneal Pharmaceuticals AMRX Stock Holding History

Park Place Capital’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,916
Closed -$8.09K – 863
2023
Q3 		$8.09K Hold
1,916
– – ﹤0.01% 793
2023
Q2 		$5.94K Hold
1,916
– – ﹤0.01% 844
2023
Q1 		$2.66K Hold
1,916
– – ﹤0.01% 921
2022
Q4 		$4K Buy
+1,916
New +$4.29K ﹤0.01% 876

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Park Place Capital's AMRX Position: Q4 2023 in Review

Park Place Capital sold out of Amneal Pharmaceuticals (AMRX) in Q4 2023, closing a stake of 1,916 shares — an estimated $8.09K sold.

Park Place Capital first reported a position in AMRX in Q4 2022 and held it in 4 quarters. The position peaked at $8.09K in Q3 2023. 153 funds tracked by Wall St. Rank hold AMRX as of Q4 2023.

  • Park Place Capital reported no remaining Amneal Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Park Place Capital sold 1,916 Amneal Pharmaceuticals shares in Q4 2023, an estimated $8.09K.
  • Park Place Capital first reported a position in Amneal Pharmaceuticals in Q4 2022 and held it in 4 quarters.
  • Park Place Capital's Amneal Pharmaceuticals position peaked at $8.09K in Q3 2023.
  • 153 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2023.

Based on Park Place Capital's 13F filing for Q4 2023, filed 24 Jan 2024.